[HTML][HTML] Mesenchymal stem cells: amazing remedies for bone and cartilage defects

P Kangari, T Talaei-Khozani… - Stem Cell Research & …, 2020 - Springer
Skeletal disorders are among the leading debilitating factors affecting millions of people
worldwide. The use of stem cells for tissue repair has raised many promises in various …

[HTML][HTML] Recent developments in clinical applications of mesenchymal stem cells in the treatment of rheumatoid arthritis and osteoarthritis

JJ Hwang, YA Rim, Y Nam, JH Ju - Frontiers in Immunology, 2021 - frontiersin.org
Mesenchymal stem cell (MSC) therapies have been used as cell-based treatments for
decades, owing to their anti-inflammatory, immunomodulatory, and regenerative properties …

[HTML][HTML] Comparison of the antioxidant effects of quercitrin and isoquercitrin: Understanding the role of the 6 ″-OH group

X Li, Q Jiang, T Wang, J Liu, D Chen - Molecules, 2016 - mdpi.com
The role of the 6 ″-OH (ω-OH) group in the antioxidant activity of flavonoid glycosides has
been largely overlooked. Herein, we selected quercitrin (quercetin-3-O-rhamnoside) and …

Chitosan/gelatin scaffolds support bone regeneration

A Georgopoulou, F Papadogiannis, A Batsali… - Journal of Materials …, 2018 - Springer
Abstract Chitosan/Gelatin (CS: Gel) scaffolds were fabricated by chemical crosslinking with
glutaraldehyde or genipin by freeze drying. Both crosslinked CS: Gel scaffold types with a …

[HTML][HTML] Mesenchymal stem cells in the treatment of osteogenesis imperfecta

E Lang, JA Semon - Cell Regeneration, 2023 - Springer
Osteogenesis imperfecta (OI) is a disease caused by mutations in different genes resulting
in mild, severe, or lethal forms. With no cure, researchers have investigated the use of cell …

[HTML][HTML] Functional tissue-engineered bone-like graft made of a fibrin scaffold and TG2 gene-modified EMSCs for bone defect repair

W Shi, Y Que, X Zhang, L Bian, X Yu, X Tang… - NPG Asia …, 2021 - nature.com
The transplantation of tissue-engineered scaffolds with stem cells is a promising therapeutic
approach for bone defect repair. To improve the therapeutic efficacy of this approach, in this …

[HTML][HTML] Effectiveness of mesenchymal stem cell-conditioned medium in bone regeneration in animal and human models: a systematic review and meta-analysis

MP Benavides-Castellanos, N Garzón-Orjuela… - Cell Regeneration, 2020 - Springer
Background Given the limitations of current therapies for the reconstruction of bone defects,
regenerative medicine has arisen as a new therapeutic strategy along with mesenchymal …

Improved therapeutic potential of MSCs by genetic modification

W Wei, Y Huang, D Li, HF Gou, W Wang - Gene therapy, 2018 - nature.com
Mesenchymal stem cells (MSCs), well-studied adult stem cells in various tissues, possess
multi-lineage differentiation potential and anti-inflammatory properties. MSCs have been …

Vascular endothelial growth factor-C induces osteogenic differentiation of human mesenchymal stem cells through the ERK and RUNX2 pathway

J Murakami, M Ishii, F Suehiro, K Ishihata… - Biochemical and …, 2017 - Elsevier
Vascular endothelial cell growth factor C (VEGF-C) is a member of the VEGF family and
plays a role in a variety of biological activities including lymphangiogenesis, angiogenesis …

Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration

N Attia, M Mashal, S Grijalvo, R Eritja, J Zárate… - … , Biology and Medicine, 2018 - Elsevier
Abstract Bone morphogenetic protein-7 (BMP-7) plays a pivotal role in the transformation of
mesenchymal stem cells (MSCs) into bone. However, its impact is hampered due to its short …